Cyclodipeptide synthases (CDPSs) use two aminoacyl-tRNA substrates in a sequential pingpong mechanism to form a cyclodipeptide. The crystal structures of three CDPSs have been determined and all show a Rossmann-fold domain similar to the catalytic domain of class-I aminoacyltRNA synthetases (aaRSs). Structural features and mutational analyses however suggest that CDPSs and aaRSs interact differently with their tRNA substrates. We used AlbC from Streptomyces noursei that mainly produces cyclo(l-Phe-l-Leu) to investigate the interaction of a CDPS with its substrates. We demonstrate that Phe-tRNA Phe is the first substrate accommodated by AlbC. Its binding to AlbC is dependent on basic residues located in the helix ␣4 that form a basic patch at the surface of the protein. AlbC does not use all of the Leu-tRNA Leu isoacceptors as a second substrate. We show that the G 1 -C 72 pair of the acceptor stem is essential for the recognition of the second substrate. Substitution of D163 located in the loop ␣6-␣7 or D205 located in the loop ␤6-␣8 affected Leu-tRNA Leu isoacceptors specificity, suggesting the involvement of these residues in the binding of the second substrate. This is the first demonstration that the two substrates of CDPSs are accommodated in different binding sites.
INTRODUCTION
Cyclodipeptide synthases (CDPSs) form a family of tRNAdependent enzymes that catalyse the synthesis of various cyclodipeptides, which are the precursors of various secondary metabolites with important biological activities (1) (2) (3) . CDPSs use two aminoacyl-tRNA (aa-tRNA) substrates in a sequential ping-pong mechanism to form the two peptide bonds of cyclodipeptides (4) (5) (6) (7) . The first catalytic steps involve the binding of the first aa-tRNA to the CDPSs and the subsequent transfer of the aminoacyl moiety onto an active-site serine residue to form an acyl-enzyme intermediate. The acyl-enzyme then reacts with the aminoacyl moiety of the second aa-tRNA substrate to form a dipeptidyl intermediate that undergoes intramolecular cyclisation, yielding the final cyclodipeptide product.
Crystal structures are available for three CDPSs (4-6). The three CDPSs share an architecture that is very similar to the catalytic domain of class-I aminoacyl-tRNA synthetases (aaRSs), especially class-Ic TyrRSs and TrpRSs. Conventional aaRSs catalyse the formation of aa-tRNAs in a two-step reaction consisting of activation of the amino acid by formation of an aminoacyl-adenylate intermediate, followed by esterification at the 3'-hydroxyl of a cognate tRNA. CDPSs would have diverged from conventional aaRSs and acquired new active site residues, converting them into cyclodipeptide-forming enzymes, for which aatRNAs are the substrates instead of the final products (8) . This evolutionary event would have entailed significant divergence between CDPSs and class-Ic aaRSs (4) (5) (6) . First, class-Ic aaRSs are homodimers that have interdigitation of the two active sites at the dimer interface whereas CDPSs are active as monomers. Second, the specific signature motifs involved in ATP binding are absent in CDPSs, consistent with the absence of ATP-dependent activation by CDPSs. Third, the tRNA-binding domain involved in interaction with the anti-codon loop of tRNA in aaRSs is absent in CDPSs. CDPSs possess instead a large patch of positively charged residues that are absent in aaRSs. Finally, unlike aaRSs, CDPSs exhibit a large tRNA substrate specificity. Although each characterized CDPS preferentially synthesizes one predominant cyclodipeptide, most of these enzymes are promiscuous and produce several cyclodipeptides. For example, AlbC from Streptomyces noursei synthesizes cyclo(L-Phe-L-Leu) (cFL) and Ndas 1148 from Nocardiopsis dassonvillei synthesizes cyclo(L-Phe-LTyr) (cFY), but both enzymes produce appreciable amounts of other phenylalanyl-containing cyclodipeptides (cyclo(LPhe-L-X), in which X indicated any of the incorporated amino acids) (cFX). Rv2275 from Mycobacterium tuberculosis mostly produces cYY but also cYX cyclodipeptides, and the YvmC enzymes from Bacillus species mainly produce cLL and cLX compounds (2, 9) .
No crystal structure has yet been obtained for a CDPS in complex with a ligand representative of its natural substrates. Nevertheless, the structural similarity between CDPSs and aaRSs, and extensive mutagenesis analyses of CDPSs have provided insight into the interaction of these enzymes with their aa-tRNA substrates (4) (5) (6) . CDPSs have a surface-accessible pocket containing the catalytic residues that superimposes well with the amino acid-binding pocket of class-Ic aaRSs. This pocket accommodates the aminoacyl moiety of one of the two aa-tRNA substrates (5) . The cyclodipeptides formed by a given CDPS almost invariably have one amino acid in common. This suggests that only the aminoacyl group of the first substrate, probably the 'common' aminoacyl group, binds and remains in the catalytic pocket, whereas the second substrate is probably accommodated at a different site with less stringent recognition (6) . The involvement of the tRNA moiety of either substrate in substrate binding and selectivity is poorly documented. Mutagenesis studies and tRNA-binding assays identified two regions of CDPSs that are likely to interact with tRNA: the positively charged patch mentioned above and a loop located between helices ␣6 and ␣7 (5,6).
Here, we studied the interaction of CDPSs with their two aa-tRNA substrates. To discriminate the interaction of either substrate with the enzyme, we worked with AlbC that uses two different substrates, Phe-tRNA Phe and LeutRNA Leu , to catalyse cFL synthesis. We show that PhetRNA Phe is specifically bound in the first step of the reaction. We also show the involvement of the nucleotide sequence of the acceptor stem in the recognition of the tRNA moiety of the second substrate and identify key bases involved in substrate specificity. Finally, we explored the role of residues predicted to interact with the tRNA moiety of the substrates and demonstrated that AlbC possesses different binding sites for its two aa-tRNA substrates.
MATERIALS AND METHODS

Mutagenesis and purification of AlbC variants
Genes coding the six new single point variants of AlbC (R80A, R102A, N159A, R160A, D163A, D205A) were obtained via polymerase chain reaction (PCR) mutagenesis of the plasmid pQE60-AlbC encoding C-terminal His 6 -tagged AlbC (5) according to the QuikChange TM site-directed mutagenesis method (Stratagene). Sequences were verified by DNA sequencing. Plasmids encoding the other AlbC variants used in this study (R91A, K94A, R98A, R98A-R99A) were constructed previously (5).
The C-terminal His 6 -tagged proteins were produced and purified as described previously (2, 5) . Purified proteins were quantified by UV spectrophotometry. Protein molecular weights were verified by electrospray ionisation mass spectrometry (Esquire HCT ion trap mass spectrometer (Bruker Daltonik, GmbH)).
In vitro transcription/semi-synthesis tRNA Phe , tRNA Leu isoacceptors and tRNA LeuTAA mutants were obtained by in vitro transcription of doublestranded DNA templates (10) . Double-stranded DNA templates were synthesized by PCR using three synthetic DNA oligonucleotides purchased from Eurogentec. For sitedirected mutagenesis of the acceptor stem, the first oligonucleotide (Matrix) includes complementary sequence of the tRNA from positions 8 to 65. To avoid mis-transcription products, a second oligonucleotide (Forward) containing the T7 promoter sequence is fused to the tRNA sequence from positions 1 to 26. Finally, a third oligonucleotide (Reverse) includes the complementary sequence of the tRNA from positions 47 to 76. Sequences of the oligonucleotides used for synthesis of tRNA Phe and tRNA Leu isoacceptors are given in Supplementary Table S1 . Amplified doublestranded DNA templates are used for in vitro transcription with T7 RNA polymerase as previously described (11) Production and purification of tRNAs were performed as previously described (13) . Briefly, cells overexpressing tRNAs were harvested by centrifugation and tRNAs were extracted by phenol followed by centrifugation steps and precipitation with ethanol. The pellet was suspended in 20 mM Tris-HCl pH 7.5, 0.1 mM EDTA, 8 mM MgCl 2 , 0.2 M NaCl and tRNAs were purified by Q-Sepharose Fast Flow column with a linear gradient of 0.4 M to 0.7 M NaCl. The fractions containing tRNAs were precipitated by isopropanol and stored at −20
• C after centrifugation and suspension in water.
Acylation of tRNAs
The concentration of aminoacylated tRNA was determined from plateau charging experiments. • C and aa-tRNAs were precipitated with 5% TCA and 0.5% casamino acids, filtered on Whatman GF/C filters and quantified by liquid scintillation counting. Mutated tRNAs were aminoacylated for different times; 15 min was enough to ensure complete acylation.
AlbC coupled assay
The CDPS activity of AlbC was determined in a coupled assay containing aaRSs to generate in situ the aa-tRNA substrates as described previously (7) . The standard assay was performed in buffer A, with 50 M Phe and Leu, 50 nM AlbC or AlbC variant, 1 M PheRS and LeuRS, and aatRNAs at the concentrations specified in the text. The reaction was carried out at 30
• C with a preincubation of 15 min with the aaRSs prior to the addition of AlbC for the synthesis of aa-tRNAs. Under these conditions, the tRNAs were completely acylated at the beginning of the AlbC reaction and remained acylated during the entire reaction (Supplementary Figure S1 ). The enzymatic reaction was initiated by the addition of AlbC. Aliquots were withdrawn at various times, acidified with 2% TFA to stop the reaction and mixed with known concentrations of stable isotope internal standards ( 13 C 9 , 15 N-labelled cFF and cFL solutions), prior to cFF and cFL quantification by liquid chromatography coupled to mass spectrometry (LC-MS) as described previously (2,7).
Detection of acyl-enzyme intermediates
Purified AlbC wild-type, pSHaeC06 (positive controls), AlbC S37A (negative control) and AlbC variants were incubated with 
RESULTS
AlbC discriminates Phe-tRNA Phe and Leu-tRNA Leu
Post-transcriptional modification of tRNAs is not required for AlbC activity. We previously showed that AlbC is active when it is produced in E. coli. AlbC mainly synthesizes cFL but also produces appreciable amounts of other L-Phe-containing cyclodipeptides, especially cFF (2). We also showed that AlbC is active in vitro. The purified enzyme can use aminoacylated tRNA Phe purified from E. coli as the substrates to produce cFF (2, 5, 7) . Based on these findings, we performed all experiments described herein using the sequences of E. coli tRNAs, in particular that of the unique tRNA Phe isoacceptor. To determine the importance of posttranscriptional modifications of tRNA Phe on AlbC activity, we compared its cFF-synthesizing activity using tRNA Phe either purified from E. coli or obtained by in vitro transcription. We used a coupled PheRS-AlbC assay to generate PhetRNA Phe in situ and measure the time course for the synthesis of cFF at various concentrations of Phe-tRNA Phe (Supplementary Figure S2 ) (7) . The rates of formation of cFF were deduced from individual kinetics and plotted against Phe-tRNA Phe concentrations ( Figure 1A ). The rate of formation of cFF was similar, regardless of the Phe-tRNA Phe used. This result shows that post-transcriptional modification of the tRNA Phe is not essential for enzymatic activity. The tRNAs used in subsequent experiments were obtained by in vitro transcription, except where otherwise stated. Figure S3) . We determined the kinetics of cFL, cFF and cLL synthesis by the coupled aaRS-AlbC assay for a fixed concentration of Phe-tRNA Phe (0.2 M) and various concentrations of each of the six tRNA Leu isoacceptors. Formation of cLL was not detected in our experimental conditions, regardless of the sequence and concentration of tRNA Leu isoacceptor. The rates of formation of the cyclodipeptides cFL and cFF were deduced from individual kinetics and plotted against Leu-tRNA Leu concentrations for each isoacceptor ( Figure 1B ). Leu-tRNA Leu isoacceptors were not used with the same catalytic efficiency by AlbC. The rates of cFL formation ( Figure 1B, (2) . Finally, the LS-MS/MS coupled assay with unlabelled substrates was used to check that the AlbC and pSHaeC06 enzyme preparations used for these experiments were fully functional.
AlbC does not use all
Specificity determinants in aa-tRNAs substrates of AlbC
The pair G 1 (Figure 2A ). This allowed comparison of PhetRNA Phe with a Leu-tRNA LeuTAA variant containing identical acceptor stems. The mutants were used as substrates in the coupled aaRS-AlbC assay. This assay was carried out as described above for the screening of Leu-tRNA Leu isoacceptors, except that the KCl concentration was 50 mM instead of 150 mM, to maximize enzymatic activity. LeutRNA LeuTAA and Leu-tRNA LeuCAG were analysed in the same experimental conditions for comparison. The results are presented in Figure 2B . The U 72 C mutation in LeutRNA LeuTAA resulted in an enzymatic activity close to that measured for the best isoacceptor, Leu-tRNA LeuCAG Leu isoacceptor substrate). These two mutants could not be obtained by in vitro transcription. They were constructed by mutagenesis from natural tRNAs and produced by overexpression in E. coli. The cFF-synthesizing activity of AlbC was more than 10-fold lower with the C 1 -G 72 tRNA Phe mutant than for the wild-type tRNA Phe ( Figure  3A ) whereas similar amounts of phenylalanyl-enzyme were formed ( Figure 3B ). These results show that AlbC does not discriminate G 1 -C 72 from C 1 -G 72 for the first substrate but does for the second one. This conclusion was also supported by comparison C 1 -G 72 and wild-type tRNA LeuCAG as the second substrate. The formation of cFL was strongly decreased by the C 1 -G 72 mutation and inhibition of cFF was also reduced ( Figure 3C ). As a wild-type tRNA LeuCAG reference, we used tRNA LeuCAG produced by overexpression in E. coli. The rates of cFL or cFF synthesis were similar to those observed with tRNA LeuCAG obtained by in vitro transcription ( Figure 3C ), indicating that post-transcriptional modification of the second aa-tRNA substrate is not essential for enzymatic activity.
Regions of AlbC involved in interaction with tRNAs
Interaction of aa-tRNAs with the basic patch of AlbC. We previously substituted each of the basic residues located in helix ␣4 with alanine. When expressed in E. coli, most of the resulting variants produced lower amounts of cFL than the wild-type enzyme, suggesting that these basic residues interact with the tRNA moiety of the substrates (5). We selected and purified AlbC variants encompassing residues distributed across the whole basic patch, namely R80A, R91A, K94A, R98A, R102A and R98A/R99A ( Figure 5 ). We first investigated the propensity of the variants to form the acyl-enzyme intermediate with either Phe-tRNA Phe or Leu-tRNA LeuCAG . Similar to the wild-type enzyme, labelled intermediates were only detected in the presence of phenylalanyl-enzyme detected was decreased for all variants. In particular, substitutions of residues R98 and R99 located in the C-terminal part of helix ␣4 prevented acylation. These results show that the basic patch of helix ␣4 of AlbC is involved in the binding of the first substrate PhetRNA Phe . We wondered if information regarding the binding of the second substrate could be obtained from measuring the activity of these different variants. We used Phe-tRNA Phe and three different Leu-tRNA Leu isoacceptors representative of the different activity patterns observed for wildtype AlbC (Leu-tRNA LeuCAG , Leu-tRNA LeuCAA and LeutRNA LeuTAA , see Figure 1B ). In standard assay conditions (50 nM AlbC or AlbC variant, 0.25 M Phe-tRNA Phe and 0.22 M Leu-tRNA Leu isoacceptor), the amounts of cyclodipeptides produced by the variants were under the detection threshold (25-30 nM). We modified the experimental conditions so that enzyme/substrate ratios were set at values similar to those used in the acyl-enzyme detection assay (i.e. 1.5 M AlbC or AlbC variant, 0.75 M PhetRNA Phe and 0.66 M Leu-tRNA Leu isoacceptor). All of the variants showed lower cyclodipeptide-synthesizing activity than the wild-type enzyme; the more affected being the variant R98A/R99A (Table 1A) . For each variant, the cFL-and cFF-synthesizing activities were decreased by the same factor, regardless of the tRNA Leu isoacceptor used. As none of the substitutions changed the pattern of use of the second substrate, it is likely that the basic residues of the helix ␣4 are not involved in its binding.
Implication of other AlbC residues in tRNA interaction.
Bonnefond et al. showed that deletion of the R158-V166 region that corresponds to the loop ␣6-␣7 abolished nonacylated tRNA Leu binding to CDPS YvmC (PDB, 3OQH) (6). To evaluate the role of this region of AlbC in tRNA binding, we substituted polar residues N159, R160, D163 and D205 with alanine (D205 belongs to the loop ␤6-␣8 but is close to N159; Figure 5 ). Incubation of the variants with [ 14 C]Phe-tRNA Phe indicated that substitutions N159A, R160A and D163A did not affect phenylalanylenzyme formation ( Figure 4B ). No labelled enzyme was detected with [ 14 C]Leu-tRNA Leu (Supplementary Figure  S5) . These results show that this region of AlbC is not involved in the binding of the first substrate. For the variant D205A, more labelled phenylalanyl-enzyme was detected Figure 5 . AlbC regions involved in interaction with tRNA substrates. The overall structure of AlbC (PDB, 3OQV) is shown in surface mode. The patch of basic residues located on helix ␣4 is coloured in blue; the residues substituted in this study are in dark blue. The loop ␣6-␣7 is coloured in green; the residues substituted in this study are in dark green. The residue D205 belonging to the loop ␤6-␣8 is coloured in dark red.
( Figure 4B ). This was the only variant for which a significant amount of leucyl-enzyme intermediate was also detected (Supplementary Figure S5) .
We next determined the activity of these variants in the presence of the different Leu-tRNA Leu isoacceptors (Table 1A). The N159A and R160A substitutions decreased cyclodipeptide production. Synthesis of cFL was more affected than that of cFF. Furthermore, the decrease in activity of the variant N159A varied according to the tRNA Leu isoacceptor used. These results suggest an involvement of both residues in the binding of the second substrate. For the variants D163A and D205A, as for the wild-type enzyme, the phenylalanine present in the enzymatic assay was completely incorporated into cFF and cFL, preventing a comparison of their activities. A new measurement was performed with reduced concentrations of enzyme and substrates (i.e. 300 nM enzyme, 0.25 M Phe-tRNA Phe and 0.22 nM Leu-tRNA LeuCAG ) (Table 1B) . Both variants synthesized much more cFF and cFL than the wild-type enzyme. In addition, the pattern of use of the different isoacceptors tRNA Leu changed. Both variants used preferentially tRNA LeuCAA , followed by tRNA LeuCAG , and then by tRNA LeuTAA . These results show that modification of residues D163 and D205 changed tRNA Leu isoacceptor specificity, indicating their involvement in the binding of the second substrate.
DISCUSSION
Here, we show that AlbC discriminates between its two substrates and possesses a different binding site for each of them. AlbC first specifically interacts with Phe-tRNA Phe , forming a phenylalanyl-enzyme intermediate. Phenylalanine is also the amino acid preferentially incorporated into cyclodipeptides synthesized by AlbC. This confirms the previous assumption that the preferred amino acid is first bound to the CDPS and remains in the catalytic pocket as an acyl-enzyme intermediate (3, 5, 6 LeuTAA has been thoroughly studied: it is not required for growth but is required for some aspects of secondary metabolism and morphological development (17) . This tRNA would be particularly involved in regulatory pathways of biosynthesis of several antibiotics. Its potential relationship with AlbC remains to be determined.
In view of these results with AlbC, one may wonder if other CDPSs share the same key determinants for the first and the second aa-tRNA substrate. Like AlbC, most of the biochemically characterized CDPSs are promiscuous and synthesize several cyclodipeptides. One exception to this rule is the CDPS Amir 4627 from Actinosynnema mirum, which synthesizes exclusively cWW when this enzyme is expressed in E. coli (18) Supplementary Figure S6) . Thus, an experimental system that uses eukaryotic tRNAs would probably give a more accurate view of N. vectensis CDPS activity. It follows that care must be taken when interpreting the results of activities of CDPSs expressed in E. coli: discrepancies between E. coli tRNA sequences and tRNA sequences in the species from which the CDPSs originates can give a misleading view of the activity of these enzymes in their natural environment.
The second important result of our work concerns the identification of two different regions of AlbC that interact with either the tRNA moiety of the first or that of the second substrate. We show that the basic patch of helix ␣4 is important for the binding of the first substrate. All the substitutions involving amino acids in this patch dramatically affected enzymatic activity in vitro, probably by perturbing the binding of the tRNA moiety. This indicates that all these residues, in particular R98 and R99, participate in the interaction. The basic patch does not belong to a clearly defined class of RNA-binding motif. It nevertheless shares features with some of them (20) . In particular, the drastic decrease of enzymatic activity that is associated with substitutions of any residues of the motif has also been described for double-stranded RNA-binding motifs (20, 21) . Arginines are essential residues for RNA binding. They are involved in non-specific interactions mediated by their positive charge. However, they also participate in specific hydrogen bonding networks with RNA bases, especially guanines (20, 22, 23) . The occurrence of arginine•guanine pairs in specific RNA-protein interactions is very high in complex structures (24) . The sequences of all the acceptor stems of aa-tRNAs used as substrates by AlbC have a high GC content, which is consistent with RNA-protein interactions involving arginines. Nonetheless, many new putative CDPSs that have been identified by Basic Local Alignment Search Tool searches (3) are devoid of the basic patch that is found in AlbC and other characterized CDPSs (2,5). These puta-
